Format

Send to

Choose Destination
JAMA Dermatol. 2019 Jan 1;155(1):15-16. doi: 10.1001/jamadermatol.2018.3753.

Pricing a Year of Progression-Free Survival: When Is the Cost of Cancer Drugs Unreasonable?

Author information

1
Department of Medical Ethics & Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
PMID:
30476974
DOI:
10.1001/jamadermatol.2018.3753
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center